Lemonade, Inc. (LMND) stock
Close on Nov 16, 2026Market cap $3.44BP/E –Yield –
Earnings
Lemonade's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Lemonade's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 18, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026after the close | $336.10M | +72.8% | -$0.56 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 29, 2026after the close | $294.40M | +79.4% | -$0.56 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 29, 2026after the close | $258.00M | +70.6% | -$0.47 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 19, 2026after the close | $228.10M | +53.3% | -$0.29 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 5, 2025after the close | $194.50M | +42.4% | -$0.51 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 5, 2025after the close | $164.10M | +34.5% | -$0.60 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 6, 2025after the close | $151.20M | +27.0% | -$0.86 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 25, 2025after the close | $148.80M | +28.8% | -$0.42 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 30, 2024after the close | $136.60M | +19.3% | -$0.95 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 30, 2024after the close | $122.00M | +16.6% | -$0.81 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 30, 2024after the close | $119.10M | +25.1% | -$0.67 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 27, 2024after the close | $115.50M | +30.7% | -$0.61 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 1, 2023after the close | $114.50M | +54.7% | -$0.88 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 2, 2023after the close | $104.60M | +109.2% | -$0.97 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 3, 2023after the close | $95.20M | +114.9% | -$0.95 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 22, 2023after the close | $88.40M | +115.6% | -$0.93 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 8, 2022after the close | $74.00M | +107.3% | -$1.37 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 8, 2022after the close | $50.00M | – | -$1.10 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 9, 2022after the close | $44.30M | – | -$1.21 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 23, 2022after the close | $41.00M | – | -$1.14 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 9, 2021after the close | $35.70M | – | -$1.08 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 4, 2021after the close | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 11, 2021after the close | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 2, 2021after the close | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 12, 2020before the open | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Lemonade's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| RevenueGAAP | Q4 FY2026 | $342.00M – $346.00M | – | New | Nov 5, 2026 |
| Adjusted EBITDAnon-GAAP | Q4 FY2026 | $5.00M – $9.00M | $8.00M | Lowered | Nov 5, 2026 |
| Gross earned premium (GEP) | Q4 FY2026 | $379.00M – $383.00M | – | Lowered | Nov 5, 2026 |
| In force premium (IFP) | Q4 FY2026 | $1.63B – $1.64B | – | New | Nov 5, 2026 |
| Stock-based compensation expense | Q4 FY2026 | $24.00M | – | Lowered | Nov 5, 2026 |
| Weighted avg. common shares | Q4 FY2026 | 78 | – | New | Nov 5, 2026 |
| RevenueGAAP | FY2026 | $1.23B – $1.24B | – | New | Nov 5, 2026 |
| Revenue | FY2026 | $1.21B – $1.22B | $1.20B – $1.20B | Raised | Jul 28, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | -$51.00M – -$47.00M | – | New | Nov 5, 2026 |
| Adjusted EBITDA lossnon-GAAP | FY2026 | -$51.00M – -$47.00M | -$51.00M – -$47.00M | Reaffirmed | Jul 28, 2026 |
| cruising velocity | FY2026 | +30% | – | New | May 6, 2025 |
| Gross earned premium (GEP) | FY2026 | $1.38B – $1.39B | – | Lowered | Nov 5, 2026 |
| Gross earned premium (GEP) | FY2026 | $1.37B – $1.38B | $1.37B – $1.37B | Lowered | Jul 28, 2026 |
| IFP growth | FY2026 | +32% | +30% | Raised | Feb 18, 2026 |
| In force premium (IFP) | FY2026 | $1.63B – $1.64B | – | New | Nov 5, 2026 |
| In force premium (IFP) | FY2026 | $1.63B – $1.64B | $1.63B – $1.64B | Raised | Jul 28, 2026 |
| Stock-based compensation expense | FY2026 | $93.00M | – | Lowered | Nov 5, 2026 |
| Stock-based compensation expense | FY2026 | $95.00M | $95.00M | Lowered | Jul 28, 2026 |
| Weighted avg. common shares | FY2026 | 77 | – | New | Nov 5, 2026 |
| Weighted avg. common shares | FY2026 | 78 | 78 | Reaffirmed | Jul 28, 2026 |
Guidance vs results
The last range Lemonade gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | Revenue | $323.00M – $326.00M | $336.10M | Above range |
| Q2 FY2026 | Revenue | $287.00M – $290.00M | $294.40M | Above range |
| Q1 FY2026 | Revenue | $246.00M – $251.00M | $258.00M | Above range |
| FY2025 | Revenue | $727.00M – $732.00M | $737.90MΣ4Q | Above range |
| Q4 FY2025 | Revenue | $217.00M – $222.00M | $228.10M | Above range |
| Q3 FY2025 | Revenue | $183.00M – $186.00M | $194.50M | Above range |
| Q2 FY2025 | Revenue | $157.00M – $159.00M | $164.10M | Above range |
| Q1 FY2025 | Revenue | $143.00M – $145.00M | $151.20M | Above range |
| Q4 FY2024 | Revenue | $144.00M – $146.00M | $148.80M | Above range |
| Q3 FY2024 | Revenue | $124.00M – $126.00M | $136.60M | Above range |
| Q2 FY2024 | Revenue | $118.00M – $120.00M | $122.00M | Above range |
| Q1 FY2024 | Revenue | $111.00M – $113.00M | $119.10M | Above range |
| Q4 FY2023 | Revenue | $107.00M – $109.00M | $115.50M | Above range |
| Q3 FY2023 | Revenue | $102.00M – $104.00M | $114.50M | Above range |
| Q2 FY2023 | Revenue | $96.00M – $98.00M | $104.60M | Above range |
| Q1 FY2023 | Revenue | $87.00M – $89.00M | $95.20M | Above range |
| Q4 FY2022 | Revenue | $77.00M – $80.00M | $88.40M | Above range |
| Q3 FY2022 | Revenue | $63.00M – $65.00M | $74.00M | Above range |
| Q2 FY2022 | Revenue | $46.00M – $48.00M | $50.00M | Above range |
| Q1 FY2022 | Revenue | $41.00M – $43.00M | $44.30M | Above range |
| Q4 FY2021 | Revenue | $39.00M – $40.00M | $41.00M | Above range |
Guidance history
Every forecast Lemonade put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 5, 2026 | Adjusted EBITDA | Q4 FY2026 | $5.00M – $9.00M | Lowered |
| Nov 5, 2026 | Adjusted EBITDA | FY2026 | -$51.00M – -$47.00M | New |
| Nov 5, 2026 | In force premium (IFP) | FY2026 | $1.63B – $1.64B | New |
| Nov 5, 2026 | Weighted avg. common shares | FY2026 | 77 | New |
| Nov 5, 2026 | Stock-based compensation expense | Q4 FY2026 | $24.00M | Lowered |
| Nov 5, 2026 | Gross earned premium (GEP) | Q4 FY2026 | $379.00M – $383.00M | Lowered |
| Nov 5, 2026 | In force premium (IFP) | Q4 FY2026 | $1.63B – $1.64B | New |
| Nov 5, 2026 | Weighted avg. common shares | Q4 FY2026 | 78 | New |
| Nov 5, 2026 | Stock-based compensation expense | FY2026 | $93.00M | Lowered |
| Nov 5, 2026 | Gross earned premium (GEP) | FY2026 | $1.38B – $1.39B | Lowered |
| Nov 5, 2026 | Revenue | FY2026 | $1.23B – $1.24B | New |
| Nov 5, 2026 | Revenue | Q4 FY2026 | $342.00M – $346.00M | New |
| Jul 28, 2026 | Adjusted EBITDA loss | FY2026 | -$51.00M – -$47.00M | Reaffirmed |
| Jul 28, 2026 | Adj. EBITDA | Q4 FY2026 | $8.00M | New |
| Jul 28, 2026 | Adjusted EBITDA loss | Q3 FY2026 | -$23.00M – -$20.00M | New |
| Jul 28, 2026 | Stock-based compensation expense | FY2026 | $95.00M | Lowered |
| Jul 28, 2026 | Stock-based compensation expense | Q3 FY2026 | $24.00M | Lowered |
| Jul 28, 2026 | Gross earned premium (GEP) | Q3 FY2026 | $356.00M – $359.00M | Lowered |
| Jul 28, 2026 | In force premium (IFP) | Q3 FY2026 | $1.54B – $1.54B | New |
| Jul 28, 2026 | Weighted avg. common shares | Q3 FY2026 | 77 | New |
| Jul 28, 2026 | Gross earned premium (GEP) | FY2026 | $1.37B – $1.38B | Lowered |
| Jul 28, 2026 | In force premium (IFP) | FY2026 | $1.63B – $1.64B | Raised |
| Jul 28, 2026 | Weighted avg. common shares | FY2026 | 78 | Reaffirmed |
| Jul 28, 2026 | Revenue | Q3 FY2026 | $323.00M – $326.00M | New |
| Jul 28, 2026 | Revenue | FY2026 | $1.21B – $1.22B | Raised |
| Apr 28, 2026 | Adjusted EBITDA loss | Q2 FY2026 | -$23.00M – -$19.00M | New |
| Apr 28, 2026 | Adjusted EBITDA loss | FY2026 | -$51.00M – -$47.00M | Raised |
| Apr 28, 2026 | Gross earned premium (GEP) | Q2 FY2026 | $328.00M – $331.00M | Lowered |
| Apr 28, 2026 | In force premium (IFP) | Q2 FY2026 | $1.43B – $1.43B | New |
| Apr 28, 2026 | Weighted avg. common shares | Q2 FY2026 | 77 | New |
| Apr 28, 2026 | Stock-based compensation expense | FY2026 | $95.00M | Lowered |
| Apr 28, 2026 | Gross earned premium (GEP) | FY2026 | $1.37B – $1.37B | Lowered |
| Apr 28, 2026 | In force premium (IFP) | FY2026 | $1.63B – $1.64B | Raised |
| Apr 28, 2026 | Weighted avg. common shares | FY2026 | 78 | Raised |
| Apr 28, 2026 | Stock-based compensation expense | Q2 FY2026 | $24.00M | Lowered |
| Apr 28, 2026 | Revenue | FY2026 | $1.20B – $1.20B | Raised |
| Apr 28, 2026 | Revenue | Q2 FY2026 | $287.00M – $290.00M | New |
| Feb 18, 2026 | Adjusted EBITDA loss | Q1 FY2026 | -$25.00M – -$22.00M | New |
| Feb 18, 2026 | Adjusted EBITDA loss | FY2026 | -$52.00M – -$48.00M | New |
| Feb 18, 2026 | Gross earned premium (GEP) | Q1 FY2026 | $299.00M – $302.00M | Lowered |
| Feb 18, 2026 | In force premium (IFP) | Q1 FY2026 | $1.32B – $1.33B | New |
| Feb 18, 2026 | Weighted avg. common shares | Q1 FY2026 | 76 | New |
| Feb 18, 2026 | Stock-based compensation expense | FY2026 | $75.00M | Lowered |
| Feb 18, 2026 | Gross earned premium (GEP) | FY2026 | $1.36B – $1.37B | Lowered |
| Feb 18, 2026 | In force premium (IFP) | FY2026 | $1.63B – $1.63B | New |
| Feb 18, 2026 | Stock-based compensation expense | Q1 FY2026 | $19.00M | Lowered |
| Feb 18, 2026 | Weighted avg. common shares | FY2026 | 77 | New |
| Feb 18, 2026 | IFP growth | FY2026 | +32% | Raised |
| Feb 18, 2026 | Revenue | FY2026 | $1.19B – $1.19B | New |
| Feb 18, 2026 | Revenue | Q1 FY2026 | $246.00M – $251.00M | New |
| Nov 5, 2025 | Adjusted EBITDA loss | Q4 FY2025 | -$16.00M – -$13.00M | New |
| Nov 5, 2025 | Adjusted EBITDA loss | FY2025 | -$130.00M – -$127.00M | New |
| Nov 5, 2025 | Gross earned premium (GEP) | FY2025 | $1.04B – $1.05B | Lowered |
| Nov 5, 2025 | Weighted avg. common shares | FY2025 | 74 | New |
| Nov 5, 2025 | In force premium (IFP) | FY2025 | $1.22B – $1.22B | New |
| Nov 5, 2025 | Stock-based compensation expense | FY2025 | $61.00M | Lowered |
| Nov 5, 2025 | Weighted avg. common shares | Q4 FY2025 | 75 | New |
| Nov 5, 2025 | In force premium (IFP) | Q4 FY2025 | $1.22B – $1.22B | New |
| Nov 5, 2025 | Gross earned premium (GEP) | Q4 FY2025 | $283.00M – $286.00M | Lowered |
| Nov 5, 2025 | Stock-based compensation expense | Q4 FY2025 | $18.00M | Lowered |
| Nov 5, 2025 | IFP growth | FY2026 | +30% | New |
| Nov 5, 2025 | Revenue | Q4 FY2025 | $217.00M – $222.00M | New |
| Nov 5, 2025 | Revenue | FY2025 | $727.00M – $732.00M | New |
| Aug 5, 2025 | Adjusted EBITDA loss | Q3 FY2025 | -$37.00M – -$34.00M | New |
| Aug 5, 2025 | Adjusted EBITDA loss | FY2025 | -$140.00M – -$135.00M | Reaffirmed |
| Aug 5, 2025 | In force premium (IFP) | FY2025 | $1.21B – $1.22B | Raised |
| Aug 5, 2025 | Stock-based compensation expense | FY2025 | $61.00M | Lowered |
| Aug 5, 2025 | Weighted avg. common shares | FY2025 | 74 | Reaffirmed |
| Aug 5, 2025 | Gross earned premium (GEP) | FY2025 | $1.04B – $1.04B | Lowered |
| Aug 5, 2025 | Weighted avg. common shares | Q3 FY2025 | 74 | New |
| Aug 5, 2025 | In force premium (IFP) | Q3 FY2025 | $1.14B – $1.15B | New |
| Aug 5, 2025 | Gross earned premium (GEP) | Q3 FY2025 | $267.00M – $269.00M | Lowered |
| Aug 5, 2025 | Stock-based compensation expense | Q3 FY2025 | $17.00M | Lowered |
| Aug 5, 2025 | Revenue | Q3 FY2025 | $183.00M – $186.00M | New |
| Aug 5, 2025 | Revenue | FY2025 | $710.00M – $715.00M | Raised |
| May 6, 2025 | Adjusted EBITDA loss | FY2025 | -$140.00M – -$135.00M | Reaffirmed |
| May 6, 2025 | Adjusted EBITDA loss | Q2 FY2025 | -$44.00M – -$41.00M | New |
| May 6, 2025 | Stock-based compensation expense | FY2025 | $60.00M | Lowered |
| May 6, 2025 | cruising velocity | FY2026 | +30% | New |
| May 6, 2025 | In force premium (IFP) | FY2025 | $1.20B – $1.21B | Raised |
| May 6, 2025 | Gross earned premium (GEP) | FY2025 | $1.03B – $1.03B | Lowered |
| May 6, 2025 | Weighted common shares | Q2 FY2025 | 73 | New |
| May 6, 2025 | In force premium (IFP) | Q2 FY2025 | $1.06B – $1.06B | New |
| May 6, 2025 | Gross earned premium (GEP) | Q2 FY2025 | $246.00M – $248.00M | Lowered |
| May 6, 2025 | Stock-based compensation expense | Q2 FY2025 | $16.00M | Lowered |
| May 6, 2025 | Weighted common shares | FY2025 | 74 | Reaffirmed |
| May 6, 2025 | FY IFP growth | FY2025 | +28% | Reaffirmed |
| May 6, 2025 | Revenue | Q2 FY2025 | $157.00M – $159.00M | New |
| May 6, 2025 | Revenue | FY2025 | $661.00M – $663.00M | Raised |
| Feb 25, 2025 | Capital expenditures | Q1 FY2025 | $2.00M | New |
| Feb 25, 2025 | Capital expenditures | FY2025 | $10.00M | New |
| Feb 25, 2025 | Adjusted EBITDA loss | Q1 FY2025 | -$49.00M – -$46.00M | New |
| Feb 25, 2025 | Adjusted EBITDA loss | FY2025 | -$140.00M – -$135.00M | New |
| Feb 25, 2025 | In force premium (IFP) | FY2025 | $1.20B – $1.21B | New |
| Feb 25, 2025 | Weighted common shares | Q1 FY2025 | 73 | New |
| Feb 25, 2025 | In force premium (IFP) | Q1 FY2025 | $997.00M – $1.00B | New |
| Feb 25, 2025 | Gross earned premium (GEP) | Q1 FY2025 | $229.00M – $231.00M | Lowered |
| Feb 25, 2025 | Stock-based compensation expense | Q1 FY2025 | $18.00M | Lowered |
| Feb 25, 2025 | Weighted common shares | FY2025 | 74 | New |
| Feb 25, 2025 | IFP growth | FY2025 | +28% | New |
| Feb 25, 2025 | Gross earned premium (GEP) | FY2025 | $1.03B – $1.03B | Lowered |
| Feb 25, 2025 | Stock-based compensation expense | FY2025 | $60.00M | Lowered |
| Feb 25, 2025 | Revenue | FY2025 | $655.00M – $657.00M | New |
| Feb 25, 2025 | Revenue | Q1 FY2025 | $143.00M – $145.00M | New |
| Oct 30, 2024 | Capital expenditures | Q4 FY2024 | $3.00M | New |
| Oct 30, 2024 | Capital expenditures | FY2024 | $10.00M | Reaffirmed |
| Oct 30, 2024 | Adjusted EBITDA Loss | Q4 FY2024 | -$29.00M – -$25.00M | New |
| Oct 30, 2024 | Adjusted EBITDA Loss | FY2024 | -$155.00M – -$151.00M | Reaffirmed |
| Oct 30, 2024 | Weighted common shares | Q4 FY2024 | 72 | New |
| Oct 30, 2024 | Stock-based compensation expense | FY2024 | $64.00M | Lowered |
| Oct 30, 2024 | Gross Earned Premium (GEP) | FY2024 | $823.00M – $826.00M | Lowered |
| Oct 30, 2024 | Weighted common shares | FY2024 | 71 | Reaffirmed |
| Oct 30, 2024 | In Force Premium (IFP) | FY2024 | $940.00M – $944.00M | Raised |
| Oct 30, 2024 | In Force Premium (IFP) | Q4 FY2024 | $940.00M – $944.00M | New |
| Oct 30, 2024 | Gross Earned Premium (GEP) | Q4 FY2024 | $222.00M – $225.00M | Lowered |
| Oct 30, 2024 | Stock-based compensation expense | Q4 FY2024 | $16.00M | Lowered |
| Oct 30, 2024 | Revenue | Q4 FY2024 | $144.00M – $146.00M | New |
| Oct 30, 2024 | Revenue | FY2024 | $522.00M – $524.00M | New |
| Jul 30, 2024 | Capital expenditures | Q3 FY2024 | $3.00M | New |
| Jul 30, 2024 | Capital expenditures | FY2024 | $10.00M | Reaffirmed |
| Jul 30, 2024 | Adjusted EBITDA loss | Q3 FY2024 | -$58.00M – -$56.00M | New |
| Jul 30, 2024 | Adjusted EBITDA loss | FY2024 | -$155.00M – -$151.00M | Reaffirmed |
| Jul 30, 2024 | Stock-based compensation expense | FY2024 | $64.00M | Lowered |
| Jul 30, 2024 | In force premium | FY2024 | $940.00M – $944.00M | Raised |
| Jul 30, 2024 | Gross earned premium | FY2024 | $818.00M – $822.00M | Lowered |
| Jul 30, 2024 | Weighted total common shares outstanding | Q3 FY2024 | 71 | New |
| Jul 30, 2024 | In force premium | Q3 FY2024 | $875.00M – $879.00M | New |
| Jul 30, 2024 | Gross earned premium | Q3 FY2024 | $208.00M – $210.00M | Lowered |
| Jul 30, 2024 | Stock-based compensation expense | Q3 FY2024 | $17.00M | Lowered |
| Jul 30, 2024 | Weighted total common shares outstanding | FY2024 | 71 | Reaffirmed |
| Jul 30, 2024 | Revenue | Q3 FY2024 | $124.00M – $126.00M | New |
| Jul 30, 2024 | Revenue | FY2024 | $511.00M – $515.00M | Reaffirmed |
| Apr 30, 2024 | Capital expenditures | FY2024 | $10.00M | New |
| Apr 30, 2024 | Capital expenditures | Q2 FY2024 | $3.00M | New |
| Apr 30, 2024 | Adjusted EBITDA loss | Q2 FY2024 | -$49.00M – -$47.00M | New |
| Apr 30, 2024 | Adjusted EBITDA loss | FY2024 | -$155.00M – -$151.00M | Raised |
| Apr 30, 2024 | Gross earned premium | FY2024 | $818.00M – $822.00M | Lowered |
| Apr 30, 2024 | Weighted total common shares outstanding | Q2 FY2024 | 70 | New |
| Apr 30, 2024 | In force premium | Q2 FY2024 | $839.00M – $841.00M | New |
| Apr 30, 2024 | Gross earned premium | Q2 FY2024 | $197.00M – $199.00M | Lowered |
| Apr 30, 2024 | Stock-based compensation expense | Q2 FY2024 | $15.00M | Lowered |
| Apr 30, 2024 | Weighted total common shares outstanding | FY2024 | 71 | Reaffirmed |
| Apr 30, 2024 | In force premium | FY2024 | $940.00M – $944.00M | Raised |
| Apr 30, 2024 | Stock-based compensation expense | FY2024 | $62.00M | Lowered |
| Apr 30, 2024 | Revenue | FY2024 | $511.00M – $515.00M | Raised |
| Apr 30, 2024 | Revenue | Q2 FY2024 | $118.00M – $120.00M | New |
| Feb 27, 2024 | Capital expenditures | Q1 FY2024 | $2.00M | New |
| Feb 27, 2024 | Capital expenditures | FY2024 | $10.00M | New |
| Feb 27, 2024 | Adjusted EBITDA loss | Q1 FY2024 | -$43.00M – -$41.00M | New |
| Feb 27, 2024 | Adjusted EBITDA loss | FY2024 | -$160.00M – -$155.00M | New |
| Feb 27, 2024 | Gross earned premium | FY2024 | $815.00M – $820.00M | Lowered |
| Feb 27, 2024 | Stock-based compensation expense | FY2024 | $60.00M | New |
| Feb 27, 2024 | Weighted total common shares outstanding | Q1 FY2024 | 70 | New |
| Feb 27, 2024 | Weighted total common shares outstanding | FY2024 | 71 | New |
| Feb 27, 2024 | In force premium | FY2024 | $938.00M – $942.00M | New |
| Feb 27, 2024 | In force premium | Q1 FY2024 | $789.00M – $791.00M | New |
| Feb 27, 2024 | Gross earned premium | Q1 FY2024 | $183.00M – $185.00M | Lowered |
| Feb 27, 2024 | Stock-based compensation expense | Q1 FY2024 | $15.00M | New |
| Feb 27, 2024 | Revenue | Q1 FY2024 | $111.00M – $113.00M | New |
| Feb 27, 2024 | Revenue | FY2024 | $505.00M – $510.00M | New |
| Nov 1, 2023 | Capital expenditures | Q4 FY2023 | $3.00M | New |
| Nov 1, 2023 | Capital expenditures | FY2023 | $10.00M | Lowered |
| Nov 1, 2023 | Adjusted EBITDA loss | Q4 FY2023 | -$44.00M – -$42.00M | New |
| Nov 1, 2023 | Adjusted EBITDA loss | FY2023 | -$188.00M – -$186.00M | Raised |
| Nov 1, 2023 | Weighted total common shares outstanding | FY2023 | 70 | Reaffirmed |
| Nov 1, 2023 | Gross earned premium | FY2023 | $665.00M – $667.00M | Lowered |
| Nov 1, 2023 | Stock-based compensation expense | FY2023 | $62.00M | Lowered |
| Nov 1, 2023 | Weighted total common shares outstanding | Q4 FY2023 | 70 | New |
| Nov 1, 2023 | In force premium | Q4 FY2023 | $726.00M – $729.00M | New |
| Nov 1, 2023 | Gross earned premium | Q4 FY2023 | $174.00M – $176.00M | Lowered |
| Nov 1, 2023 | Stock-based compensation expense | Q4 FY2023 | $16.00M | Lowered |
| Nov 1, 2023 | In force premium | FY2023 | $726.00M – $729.00M | Raised |
| Nov 1, 2023 | Revenue | FY2023 | $421.00M – $423.00M | New |
| Nov 1, 2023 | Revenue | Q4 FY2023 | $107.00M – $109.00M | New |
| Aug 2, 2023 | Capital expenditures | FY2023 | $12.00M | New |
| Aug 2, 2023 | Capital expenditures | Q3 FY2023 | $3.00M | New |
| Aug 2, 2023 | Adjusted EBITDA loss | Q3 FY2023 | -$51.00M – -$49.00M | New |
| Aug 2, 2023 | Adjusted EBITDA loss | FY2023 | -$199.00M – -$196.00M | Raised |
| Aug 2, 2023 | Gross earned premium | FY2023 | $654.00M – $658.00M | Lowered |
| Aug 2, 2023 | Weighted total common shares outstanding | Q3 FY2023 | 70 | New |
| Aug 2, 2023 | In force premium | Q3 FY2023 | $703.00M – $706.00M | New |
| Aug 2, 2023 | Gross earned premium | Q3 FY2023 | $166.00M – $168.00M | Lowered |
| Aug 2, 2023 | Stock-based compensation expense | Q3 FY2023 | $16.00M | New |
| Aug 2, 2023 | Weighted total common shares outstanding | FY2023 | 70 | Reaffirmed |
| Aug 2, 2023 | In force premium | FY2023 | $710.00M – $715.00M | Raised |
| Aug 2, 2023 | Stock-based compensation expense | FY2023 | $62.00M | New |
| Aug 2, 2023 | Revenue | FY2023 | $402.00M – $408.00M | Raised |
| Aug 2, 2023 | Revenue | Q3 FY2023 | $102.00M – $104.00M | New |
| May 3, 2023 | Capital expenditures | Q2 FY2023 | $3.00M | New |
| May 3, 2023 | Capital expenditures | FY2023 | $12.00M | Raised |
| May 3, 2023 | Adjusted EBITDA loss | Q2 FY2023 | -$58.00M – -$55.00M | New |
| May 3, 2023 | Adjusted EBITDA loss | FY2023 | -$205.00M – -$200.00M | Raised |
| May 3, 2023 | Gross earned premium | FY2023 | $645.00M – $650.00M | Lowered |
| May 3, 2023 | Stock-based compensation expense | FY2023 | $60.00M | Lowered |
| May 3, 2023 | Weighted total common shares outstanding | Q2 FY2023 | 70 | New |
| May 3, 2023 | Weighted total common shares outstanding | FY2023 | 70 | Lowered |
| May 3, 2023 | In force premium at December 31 | FY2023 | $700.00M – $705.00M | Raised |
| May 3, 2023 | In force premium at June 30, 2023 | Q2 FY2023 | $665.00M – $668.00M | New |
| May 3, 2023 | Gross earned premium | Q2 FY2023 | $156.00M – $158.00M | Lowered |
| May 3, 2023 | Stock-based compensation expense | Q2 FY2023 | $15.00M | Lowered |
| May 3, 2023 | Revenue | Q2 FY2023 | $96.00M – $98.00M | New |
| May 3, 2023 | Revenue | FY2023 | $392.00M – $396.00M | Raised |
| Feb 22, 2023 | Capital expenditures | Q1 FY2023 | $2.00M | New |
| Feb 22, 2023 | Capital expenditures | FY2023 | $8.00M | New |
| Feb 22, 2023 | Adjusted EBITDA loss | Q1 FY2023 | -$65.00M – -$63.00M | New |
| Feb 22, 2023 | Adjusted EBITDA loss | FY2023 | -$245.00M – -$240.00M | New |
| Feb 22, 2023 | Stock-based compensation expense | FY2023 | $60.00M | Lowered |
| Feb 22, 2023 | In force premium at December 31 | FY2023 | $695.00M – $700.00M | New |
| Feb 22, 2023 | Gross earned premium | FY2023 | $632.00M – $636.00M | Lowered |
| Feb 22, 2023 | Weighted total common shares outstanding | Q1 FY2023 | 70 | New |
| Feb 22, 2023 | In force premium at March 31 | Q1 FY2023 | $635.00M – $637.00M | New |
| Feb 22, 2023 | Gross earned premium | Q1 FY2023 | $148.00M – $150.00M | Lowered |
| Feb 22, 2023 | Stock-based compensation expense | Q1 FY2023 | $15.00M | Lowered |
| Feb 22, 2023 | Weighted total common shares outstanding | FY2023 | 72 | New |
| Feb 22, 2023 | Revenue | FY2023 | $375.00M – $379.00M | New |
| Feb 22, 2023 | Revenue | Q1 FY2023 | $87.00M – $89.00M | New |
| Nov 8, 2022 | Capital expenditures | FY2022 | $11.00M | Raised |
| Nov 8, 2022 | Capital expenditures | Q4 FY2022 | $3.00M | New |
| Nov 8, 2022 | Adjusted EBITDA loss | Q4 FY2022 | -$65.00M – -$62.00M | New |
| Nov 8, 2022 | Adjusted EBITDA loss | FY2022 | -$238.00M – -$235.00M | Raised |
| Nov 8, 2022 | Stock-based compensation expense | FY2022 | $60.00M | Lowered |
| Nov 8, 2022 | Weighted total common shares outstanding | FY2022 | 65 | Lowered |
| Nov 8, 2022 | Weighted total common shares outstanding | Q4 FY2022 | 70 | New |
| Nov 8, 2022 | In force premium | Q4 FY2022 | $612.00M – $615.00M | New |
| Nov 8, 2022 | Gross earned premium | Q4 FY2022 | $147.00M – $150.00M | Lowered |
| Nov 8, 2022 | Stock-based compensation expense | Q4 FY2022 | $16.00M | Lowered |
| Nov 8, 2022 | In force premium | FY2022 | $612.00M – $615.00M | Raised |
| Nov 8, 2022 | Gross earned premium | FY2022 | $486.00M – $489.00M | Lowered |
| Nov 8, 2022 | Revenue | Q4 FY2022 | $77.00M – $80.00M | New |
| Nov 8, 2022 | Revenue | FY2022 | $245.00M – $248.00M | New |
| Aug 8, 2022 | Capital expenditures | Q3 FY2022 | $3.00M | New |
| Aug 8, 2022 | Capital expenditures | FY2022 | $10.00M | Reaffirmed |
| Aug 8, 2022 | Adjusted EBITDA loss | Q3 FY2022 | -$74.00M – -$69.00M | New |
| Aug 8, 2022 | Adjusted EBITDA loss | FY2022 | -$245.00M – -$240.00M | Raised |
| Aug 8, 2022 | Stock-based compensation expense | FY2022 | $60.00M | Lowered |
| Aug 8, 2022 | In force premium | FY2022 | $610.00M – $615.00M | Raised |
| Aug 8, 2022 | Gross earned premium | FY2022 | $476.00M – $480.00M | Lowered |
| Aug 8, 2022 | Weighted total common shares outstanding | Q3 FY2022 | 67 | New |
| Aug 8, 2022 | In force premium | Q3 FY2022 | $595.00M – $600.00M | New |
| Aug 8, 2022 | Gross earned premium | Q3 FY2022 | $127.00M – $129.00M | Lowered |
| Aug 8, 2022 | Stock-based compensation expense | Q3 FY2022 | $16.00M | Lowered |
| Aug 8, 2022 | Weighted total common shares outstanding | FY2022 | 70 | New |
| Aug 8, 2022 | Revenue | Q3 FY2022 | $63.00M – $65.00M | New |
| Aug 8, 2022 | Revenue | FY2022 | $236.00M – $239.00M | Raised |
| May 9, 2022 | Capital expenditures | Q2 FY2022 | $4.00M | New |
| May 9, 2022 | Capital expenditures | FY2022 | $14.00M | New |
| May 9, 2022 | Adjusted EBITDA loss | Q2 FY2022 | -$70.00M – -$65.00M | New |
| May 9, 2022 | Adjusted EBITDA loss | FY2022 | -$280.00M – -$265.00M | Raised |
| May 9, 2022 | Stock-based compensation expense | FY2022 | $60.00M | Lowered |
| May 9, 2022 | In force premium | FY2022 | $535.00M – $545.00M | Raised |
| May 9, 2022 | Gross earned premium | FY2022 | $426.00M – $430.00M | Lowered |
| May 9, 2022 | In force premium | Q2 FY2022 | $445.00M – $450.00M | New |
| May 9, 2022 | Gross earned premium | Q2 FY2022 | $103.00M – $105.00M | Lowered |
| May 9, 2022 | Stock-based compensation expense | Q2 FY2022 | $15.00M | Lowered |
| May 9, 2022 | Revenue | Q2 FY2022 | $46.00M – $48.00M | New |
| May 9, 2022 | Revenue | FY2022 | $205.00M – $208.00M | Raised |
| Feb 23, 2022 | Capital expenditures | FY2022 | $10.00M | New |
| Feb 23, 2022 | Capital expenditures | Q1 FY2022 | $2.00M | New |
| Feb 23, 2022 | Adjusted EBITDA loss | Q1 FY2022 | -$70.00M – -$65.00M | New |
| Feb 23, 2022 | Adjusted EBITDA loss | FY2022 | -$290.00M – -$275.00M | New |
| Feb 23, 2022 | In force premium | Q1 FY2022 | $405.00M – $410.00M | New |
| Feb 23, 2022 | Gross earned premium | Q1 FY2022 | $92.00M – $94.00M | Lowered |
| Feb 23, 2022 | Stock-based compensation expense | Q1 FY2022 | $20.00M | Lowered |
| Feb 23, 2022 | total annual IFP growth | FY2022 | +70% | New |
| Feb 23, 2022 | In force premium | FY2022 | $530.00M – $540.00M | New |
| Feb 23, 2022 | Gross earned premium | FY2022 | $423.00M – $427.00M | Lowered |
| Feb 23, 2022 | Stock-based compensation expense | FY2022 | $80.00M | Lowered |
| Feb 23, 2022 | Revenue | FY2022 | $202.00M – $205.00M | New |
| Feb 23, 2022 | Revenue | Q1 FY2022 | $41.00M – $43.00M | New |
| Nov 8, 2021 | Capital expenditures | Q4 FY2021 | $3.00M | New |
| Nov 8, 2021 | Capital expenditures | FY2021 | $11.00M | New |
| Nov 8, 2021 | Adjusted EBITDA loss | Q4 FY2021 | -$52.00M – -$50.00M | New |
| Nov 8, 2021 | Adjusted EBITDA loss | FY2021 | -$185.00M – -$183.00M | New |
| Nov 8, 2021 | In force premium | FY2021 | $380.00M – $384.00M | New |
| Nov 8, 2021 | Stock-based compensation expense | FY2021 | $50.00M | Lowered |
| Nov 8, 2021 | Stock-based compensation expense | Q4 FY2021 | $19.00M | Lowered |
| Nov 8, 2021 | Gross earned premium | FY2021 | $291.00M – $292.00M | Lowered |
| Nov 8, 2021 | In force premium | Q4 FY2021 | $380.00M – $384.00M | New |
| Nov 8, 2021 | Gross earned premium | Q4 FY2021 | $88.00M – $89.00M | Lowered |
| Nov 8, 2021 | Revenue | Q4 FY2021 | $39.00M – $40.00M | New |
| Nov 8, 2021 | Revenue | FY2021 | $126.00M – $127.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Lemonade filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?